Eastman Chemical Company
NYSE:EMNChemicals
-$1.16 today
- Market cap
- $7.13B
- Beta
- 1.07
- P/E (TTM)
- 20.6
- EPS (TTM)
- $3.50
- Dividend yield
- 4.65%
Volume 1.38M
Average 1.33M
EMN Account Payables
Amounts the company owes suppliers for goods and services received.
Eastman Chemical CompanyNYSE: EMN
Account Payables · Q2 FY2026 · quarter ended Jun 2026
Account payables rises 3.3% from a year ago
Account payables stood at $2.08B at the end of Q2 FY2026, up 3.3% from a year earlier and up 4.4% from the prior quarter. Over 3 fiscal years it compounded at -2.8% a year.
Context
- Account payables amounted to 13.5% of total assets at the end of Q2 FY2026, up 0.3 pp from a year earlier.
- Account payables increased in 1 of the last 3 fiscal years.
What to watch
Whether account payables keeps rising in the next quarterly balance sheet after a +3.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 1.21B USD
- Year-over-year change
- -7.5%
- 4-year CAGR
- -0.3%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.21B | -7.5% |
| FY2024 | 2024-12-31 | 1.31B | +11.9% |
| FY2023 | 2023-12-31 | 1.17B | -11.3% |
| FY2022 | 2022-12-31 | 1.32B | +7.4% |
| FY2021 | 2021-12-31 | 1.23B | — |
Account Payables vs competitors
How EMN compares with its peers on the latest reported figures
- EMN's Jun 2026 account payables of $2.08B is the 2nd highest of the 11 companies compared; the peer median is $363.05M.
- Its year-over-year change of +3.3% is the 8th highest of 11, against a peer median of +12.3%.
- Account payables amounts to 13.5% of total assets for EMN, versus a peer median of 8.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $5.3B | +16.9% | -5.6% | 8.7% | |
| Jun 2026 | $2.08B | +3.3% | -2.8% | 13.5% | |
| Sep 2026 | $857M | -60.1% | -6.0% | 4.4% | |
| Mar 2026 | $843M | +14.2% | -9.1% | 11.8% | |
| Jun 2026 | $670M | +12.4% | -4.9% | 16.9% | |
| Sep 2026 | $440.4M | +12.1% | -3.4% | 7.4% | |
| Mar 2026 | $285.7M | -4.2% | -11.4% | 12.2% | |
| Sep 2026 | $199.2M | +37.2% | +7.8% | 3.4% | |
| Jun 2026 | $198M | +7.0% | -10.7% | 4.3% | |
| Jun 2026 | $169.4M | +13.4% | +1.9% | 9.2% | |
| Sep 2026 | $82.4M | -18.3% | -19.3% | 5.5% | |
| Peer median (excluding EMN) | $363.05M | +12.3% | -5.8% | 8.1% | |
Competitors are the stored peer set for EMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 459M | 493M | 548M | 837M | 566M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 1.58B | 1.28B | 1.15B | 1.17B | 999M |
| Inventory | 1.5B | 1.89B | 1.68B | 1.99B | 1.98B |
| Other Current Assets | 1.1B | 114M | 96M | 104M | 100M |
| Total Current Assets | 4.65B | 3.78B | 3.48B | 4.1B | 3.65B |
| Property, Plant & Equipment (Net) | 5B | 5.16B | 5.55B | 5.62B | 5.92B |
| Goodwill | 3.64B | 3.66B | 3.65B | 3.63B | 3.67B |
| Intangible Assets | 1.36B | 1.21B | 1.14B | 1.03B | 970M |
| Long-term Investments | 145M | 183M | 124M | 186M | 111M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 729M | 672M | 696M | 647M | 546M |
| Total Non-current Assets | 10.87B | 10.89B | 11.15B | 11.11B | 11.21B |
| Total Assets | 15.52B | 14.67B | 14.63B | 15.21B | 14.86B |
| Account Payables | 1.23B | 1.32B | 1.17B | 1.31B | 1.21B |
| Short-term Debt | 797M | 1.13B | 593M | 499M | 642M |
| Tax Payables | 138M | 157M | 192M | 290M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 326M | 391M | 218M | 379M | 396M |
| Total Current Liabilities | 2.97B | 3.25B | 2.58B | 2.71B | 2.65B |
| Long-term Debt | 4.57B | 4.03B | 4.43B | 4.66B | 4.32B |
| Deferred Tax Liabilities | 810M | 671M | 601M | 533M | 669M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.22B | 1.48B | 1.38B | 1.36B | 1.07B |
| Total Non-current Liabilities | 6.76B | 6.18B | 6.53B | 6.65B | 6.17B |
| Total Liabilities | 9.73B | 9.43B | 9.1B | 9.36B | 8.82B |
| Common Stock | 2M | 2M | 2M | 2M | 2M |
| Retained Earnings | 8.56B | 8.97B | 9.49B | 10.01B | 10.11B |
| Accumulated OCI | (182M) | (205M) | (319M) | (314M) | (160M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 84M | 83M | 72M | 73M | 76M |
| Total Equity | 5.79B | 5.24B | 5.53B | 5.85B | 6.04B |
| Total Debt | 5.52B | 5.15B | 5.14B | 5.26B | 5.08B |
| Net Debt | 5.06B | 4.66B | 4.59B | 4.42B | 4.51B |
Eastman Chemical Company
NYSE:EMN
Intrinsic Alpha fair value
Locked
Current Price
$62.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.